Word

INTELLECTIVE

Status

Pending

Status Code

661

Status Date

Monday, September 16, 2024

Serial Number

79378706

Mark Type

3

Filing Date

Tuesday, June 13, 2023

Trademark Owner History

Intellective Biologics (Suzhou) Co., Ltd. - 1st New Owner Before Publication
NaTurtle AG - Original Applicant

Classifications

5 Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions

1 Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes

42 Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for others

The mark consists of the stylized wording "INTELLECTIVE" with the letters "LL" forming the legs of a person with outstretched arms.

Trademark Events

Sep 19, 2023

Application Filing Receipt Mailed

Dec 10, 2023

Change Of Name/Address Rec'd From Ib

Sep 14, 2023

Sn Assigned For Sect 66a Appl From Ib

Sep 15, 2023

New Application Office Supplied Data Entered

Oct 27, 2023

Change Of Owner Received From Ib

Mar 4, 2024

Assigned To Examiner

Mar 4, 2024

Non-Final Action Written

Mar 5, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Mar 30, 2024

Non-Final Action (Ib Refusal) Withdrawn For Review

Apr 4, 2024

Non-Final Action (Ib Refusal) Prepared For Review

May 13, 2024

Refusal Processed By Ib

Sep 16, 2024

Teas/Email Correspondence Entered

Sep 16, 2024

Correspondence Received In Law Office

Sep 16, 2024

Teas Response To Office Action Received

Apr 23, 2024

Refusal Processed By Mpu

Apr 3, 2024

Non-Final Action Written

Apr 23, 2024

Non-Final Action Mailed - Refusal Sent To Ib